Scendea

Scendea is a specialized consultancy firm offering integrated product development, regulatory strategy, and compliance services to biopharma innovators and investors. Leveraging over 20 years of collective industry experience and involvement in more than 1,000 development programs, the company delivers scientifically grounded, jurisdiction-specific solutions to accelerate the path to market for medicinal products. Its business model is purely service-based, catering to a diverse clientele from academic spin-outs to large pharmaceutical companies, with additional services for investors seeking due diligence and portfolio support. The company is privately held and operates as a global consultancy with a strong emphasis on quality and regulatory insight.

Integrated service model providing scientific, regulatory, and compliance expertise across Non-Clinical, CMC, Clinical, and Regulatory functions. Includes dedicated Compliance division for CRO/CDMO oversight, GxP audits, QMS support, and training.

Scendea competes with large global CROs offering regulatory consulting, smaller niche regulatory affairs consultancies, and the internal departments of large pharmaceutical companies. Its differentiation lies in its integrated product development and compliance service model, mid-sized agility, and deep, cross-functional expertise.